Screening for familial hypercholesterolaemia : Effective, safe treatments and DNA testing make screening attractive

door Kastelein, J J P
Gepubliceerd in 2000

Thyroid Hormone Mimetics: the Past, Current Status and Future Challenges

door Elbers, L.P.B., Kastelein, J.J.P., Sjouke, B.
Gepubliceerd in Curr Atheroscler Rep (2016)

Familial Hypercholesterolemia: Present and Future Management

door Sjouke, B., Kusters, D. M., Kastelein, J. J. P., Hovingh, G. K.
Gepubliceerd in 2011

HindIII-polymorphism in the LPL-gene detected by PCR

door Bruin, T., Reymer, P.W.A., Groenemeyer, B.E., Talmud, P.J., Kastelein, J.J.P.
Gepubliceerd in 1991

The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins

door Friedrich, S, Kastelein, J J P, James, D, Waterhouse, T, Nissen, S E, Nicholls, S J, Krueger, K A
Gepubliceerd in 2014

Triglycerides and Cardiovascular Risk

door Harchaoui, K.E.L, Visser, M.E, Kastelein, J.J.P, Stroes, E.S, Dallinga-Thie, G.M
Gepubliceerd in 2009

Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia

door van Wissen, S, Smilde, T J, Trip, M D, de Boo, Th, Kastelein, J J P, Stalenhoef, A F H
Gepubliceerd in 2003

Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia

door Huijgen, R., Fouchier, S. W., Denoun, M., Hutten, B. A., Vissers, M. N., Lambert, G., Kastelein, J. J. P.
Gepubliceerd in 2012

Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial

door Jakulj, L., Vissers, M. N., Groen, A. K., Hutten, B. A., Lutjohann, D., Veltri, E. P., Kastelein, J. J. P.
Gepubliceerd in 2010

Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes

door Kusters, D. M., Huijgen, R., Defesche, J. C., Vissers, M. N., Kindt, I., Hutten, B. A., Kastelein, J. J. P.
Gepubliceerd in 2011

Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study

door Sivapalaratnam, S., Boekholdt, S.M., Trip, M.D., Sandhu, M.S., Luben, R., Kastelein, J.J.P., Wareham, N.J., Khaw, K.
Gepubliceerd in 2010

Genome-Wide Association Studies in Atherosclerosis

door Sivapalaratnam, S., Motazacker, M. M., Maiwald, S., Hovingh, G. K., Kastelein, J. J. P., Levi, M., Trip, M. D., Dallinga-Thie, G. M.
Gepubliceerd in 2011

Enhancing reverse cholesterol transport/raising HDL cholesterol: new options for prevention and treatment of cardiovascular disease

door Jukema, J.W., Lenselink, M., de Grooth, G.J., Boekholdt, S.M., Liem, A.H., Kuivenhoven, J.-A., Kastelein, J.J.P.
Gepubliceerd in 2004

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis

door Wijbrandts, C A, van Leuven, S I, Boom, H D, Gerlag, D M, Stroes, E G S, Kastelein, J J P, Tak, P P
Gepubliceerd in 2008

Carotid intima–media thickness in post-coarctectomy patients with exercise induced hypertension

door Vriend, J W J, de Groot, E, Bouma, B J, Hrudova, J, Kastelein, J J P, Tijssen, J G P, Mulder, B J M
Gepubliceerd in 2005

Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in...

door Holleboom, A. G., Kuivenhoven, J. A., Vergeer, M., Hovingh, G. K., van Miert, J. N., Wareham, N. J., Kastelein, J. J. P., Khaw, K-T., Boekholdt, S. M.
Gepubliceerd in 2010

Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia

door van Dam, M, Zwart, M, de Beer, F, Smelt, A H M, Prins, M H, Trip, M D, Havekes, L M, Lansberg, P J, Kastelein, J J P
Gepubliceerd in 2002

Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus

door Nieuwdorp, M., Vergeer, M., Bisoendial, R. J., op ‘t Roodt, J., Levels, H., Birjmohun, R. S., Kuivenhoven, J. A., Basser, R., Rabelink, T. J., Kastelein, J. J. P., Stroes, E. S. G.
Gepubliceerd in 2008

Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis

door Nieuwdorp, M., Holleman, F., de Groot, E., Vink, H., Gort, J., Kontush, A., Chapman, M. J., Hutten, B. A., Brouwer, C. B., Hoekstra, J. B. L., Kastelein, J. J. P., Stroes, E. S. G.
Gepubliceerd in 2007

Apolipoprotein C-III levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study

door van Capelleveen, J.C., Moens, S.J. Bernelot, Yang, X., Kastelein, J.J.P., Wareham, N.J., Zwinderman, A.H., Stroes, E.S.G., Witztum, J.L., Hovingh, G.K., Khaw, K.T., Boekholdt, S.M., Tsimikas, S.
Gepubliceerd in Arterioscler Thromb Vasc Biol (2017)